Hemoglobin A_o and α-Crosslinked Hemoglobin (α-DBBF) Potentiate Agonist-Induced Platelet Aggregation Through the Platelet Thromboxane Receptor

References

• Winslow RM. Hemoglobin-based Red Cell Substitutes. Johns Hopkins University Press, Baltimore, MD 1992; 136–163
   Google Scholar
• Hess J R, MacDonald V W, Brinkely WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74: 1769–1778
   PubMed Web of Science ®Google Scholar
• Alayash A I, Fratantoni J C, Bonaventura C, Bonaventura J, Cashon RE. Nitric oxide binding to human ferrihemoglobins cross-linked between either alpha or beta subunits. Arch Biochem Biophys 1993; 303: 332–338
   PubMed Web of Science ®Google Scholar
• Chatterje R, Welty E V, Walder R Y, Pruitt S L, Rogers P H, Arnone A, Walder JA. Isolation and characterization of a new hemoglobin derivative cross-linked between the α chains (lysine 99αl-lysine 99α2). J Biol Chem 1986; 261: 9929–9937
   PubMedGoogle Scholar
• Ranney H M, Sharma V. Structure and function of hemoglobin. Williams Hematology, E Beutler, MA Lichtman, BS Coller, TJ Kipps. McGraw Hill, New York, NY 1995; 417–425
   Google Scholar
• Cashon R E, Alayash AI. Reactions of human hemoglobin A0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch Biochem Biophys 1995; 316: 461–469
   PubMed Web of Science ®Google Scholar
• Puppo A, Halliwell B. Formation of hydroxyl radicals in biological systems: Does myoglobin stimulate hydroxyl radical formation. Free Radic Res Commun 1988; 4: 415–422
   PubMed Web of Science ®Google Scholar
• Faasen A E, Sundby R, Panter S S, Condie R M, Hedlund BE. Hemoglobin: A lifesaver and an oxidant. How to tip the balance. Biomat Art Cells Art Org 1988; 16: 93–104
   PubMedGoogle Scholar
• Moncada S, Palmer R MJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1989; 43: 109–142
   Google Scholar
• Alayash A I, Fratantoni J C, Bonaventura C, Bonaventura J, Bucci E. Consequences of chemical modifications on the free radical reactions of human hemoglobin. Arch Biochem Biophys 1992; 298: 114–120
   PubMed Web of Science ®Google Scholar
• Bolin R, Smith D, Moore G, Boswell G, DeVenuto F. Hematologic effects of hemoglobin solutions in animals. Prog Clin Biol Res 1983; 122: 117–126
   PubMedGoogle Scholar
• White C T, Murray A J, Greene J R, Smith D J, Medina F, Makovec G T, Martin E J, Bolin RB. Toxicity of human hemoglobin solution infused into rabbits. J Lab Clin Med 1986; 108: 121–131
   PubMed Web of Science ®Google Scholar
• Iuliano L, Violi F, Pedersen J Z, Pratico D, Rotilio G, Balsano F. Free radical-mediated platelet acitvation by hemoglobin released from red blood cells. Arch Biochem Biophys 1992; 299: 220–224
   PubMed Web of Science ®Google Scholar
• Olsen S B, Tang D B, Jackson M R, Gomez E R, Ayala B, Alving BM. Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation 1996; 93: 327–332
   PubMed Web of Science ®Google Scholar
• Nakashima S, Tohmatsu T, Hattori H, Okano Y, Nozawa Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis, and calcium mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Comm 1986; 135: 1099–1104
   PubMedGoogle Scholar
• Christensen S M, Medina F, Winslow R W, Snell S M, Zegna A, Marini MA. Preparation of human hemoglobin A0 for possible use as a blood substitute. J Biochem Biophys Meth 1988; 17: 143–154
   PubMedGoogle Scholar
• Snyder SR, Welty E V, Walder R Y, Williams L A, Walder JA. HbXL99 alpha: A hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Proc Natl Acad Sci USA 1987; 84: 7280–7284
   PubMed Web of Science ®Google Scholar
• Di Iorio EE. Preparation of derivatives of ferrous and ferric hemoglobin. Methods Enzymol 1981; 76: 57–72
   PubMedGoogle Scholar
• Fratantoni J C, Poindexter BJ. Measuring platelet aggregation with a microplate reader: A new technical approach to platelet aggregation studies. Am J Clin Pathol 1993; 94: 613–617
   Google Scholar
• Thé TH, Feltkamp T EW. Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunol 1970; 18: 875–81
   Google Scholar
• Faraday N, Goldschmidt-Clermont P, Dise K, Bray PF. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med 1994; 123: 728–740
   PubMed Web of Science ®Google Scholar
• Bundy GL. The synthesis of prostaglandin endoperoxide analogs. Tetrahedron Lett 1975; 24: 1957–1960
   Google Scholar
• Born G VR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–929
   PubMed Web of Science ®Google Scholar
• Dickerson R E, Geis I. Hemoglobin: Structure, Function, Evolution and Pathology. Benjamin/Cummings Publishing, Menlo Park, CA 1983; 66–72
   Google Scholar
• Rao G HR, White JG. Disaggregation and reaggregation of “irreversibly” aggregated platelets: A method for more complete evaluation of anti-platelet drugs. Agents Actions 1985; 16: 425–433
   PubMedGoogle Scholar
• Goldberg M R, Robertson Yohimbine D. A pharmacological probe for study of the alpha 2-αdrenoreceptor. Pharmacol Rev 1983; 35: 143–180
   PubMed Web of Science ®Google Scholar
• Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58–178
   PubMed Web of Science ®Google Scholar
• Hargreaves P G, Licking E F, Sargeant P, Sage S O, Barnes M J, Farndale RW. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen. Thromb Haemost 1994; 72: 634–642
   PubMedGoogle Scholar
• Lapetina EG. The signal transduction induced by thrombin in human platelets. FEBS Lett 1990; 268: 400–404
   PubMed Web of Science ®Google Scholar
• Turini M E, Holub BJ. Eicosanoid/thromboxane A2-independent and — dependent generation of lysoplasmenylehtanolamine via phospholipase A2 in collagen-stimulated human platelets. Biochem J 1993; 289: 641–646
   PubMed Web of Science ®Google Scholar
• Darius H, Smith J B, Lefer AM. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. J Pharmacol Exp Ther 1985; 235: 274–281
   PubMedGoogle Scholar
• Bennett J S, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393–1401
   PubMed Web of Science ®Google Scholar
• Kieffer N, Phillips DR. Platelet membrane glycoproteins: Functions in cellular interactions. Ann Rev Cell Bio 1990; 6: 329–357
   PubMedGoogle Scholar
• Korn ED. Biochemistry of actomyosin-dependent cell motility. Proc. Natl. Acad. Sci. USA 1978; 75: 588–599, (1978)
   PubMed Web of Science ®Google Scholar
• Fox J EB. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884–893
   PubMed Web of Science ®Google Scholar
• Savitsky J P, Doczi J, Black J, Arnold JD. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23: 73–80
   PubMed Web of Science ®Google Scholar
• Zilletti L, Ciuffi M, Franchi-Micheli S, Fusi F, Gentilini G, Moneti G, Valoti M, Sgaragli GP. Cyclooxygenase activity of hemoglobin. Methods Enzymol 1994; 231: 562–573
   PubMedGoogle Scholar
• Kühn H, Götze R, Schewe T, Rapoport SM. Quasi-lipoxygenase activity of haemoglobin: A model for lipoxygenases. Eur J Biochem 1981; 120: 161–168
   PubMedGoogle Scholar
• Rioux F, Drapeau G, Audet R, Burhop K E, Marceau F. Mechanism of the contractile effect of diaspirin-cross-linked hemoglobin in rat isolated aorta strip denuded of endothelium as revealed using an oil-immersion procedure. Can J Physiol Pharmacol 1996; 74: 1171–1179
   PubMed Web of Science ®Google Scholar
• Gawaz M P, Loftus J C, Bajt M L, Frojmovic M M, Plow E F, Ginsberg MH. Ligand bridging mediates integrin αIIbβ3 (platelet GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest 1991; 88: 1128–1134
   PubMed Web of Science ®Google Scholar